Asmatab 10 mg Tab.

Montelukast is indicated for the prophylaxis and chronic treatment of asthma in adults and pediatric patients l2 months of age and older- It is indicated for prevention of exercise-induced bronchoconstriction (EIB) in patients 1 5 years of age and older. It is also indicated for the relief of symptoms of seasonal allergic rhinitis in patients 2 years of age and older and perennial allergic rhinitis in adult patients.

Asthma – For adults and adolescents 15 years of age and older: One 10 mg tablet. Children 6-14 years of age: One 5 mg chewable tablet. Safety and effectiveness in pediatric patients less than 12 months of age with asthma have not been established.

Exercise-Induced Bronchoconstriction (EIB) – For prevention of EIB, a single dose of Montelukast should be taken at least 2 hours before exercise. The recommended dose for adults and adolescents 15 years of age and older is one 10 mg tablet. Children 6 to 14 years of age: One 5 mg chewable tablet.

Allergic Rhinitis – The recommended dose for the treatment of symptoms of seasonal allergic rhinitis is for adults and adolescents 15 years of age and older: One 10 mg tablet. Children 6-14 years of age: One 5 mg chewable tablet. Safety and effectiveness in pediatric patients younger than 2 years of age with seasonal allergic rhinitis have not been established. The recommended dose for the treatment of symptoms of perennial allergic rhinitis is for adults and adolescents 15 years of age and older: One 10 mg tablet. Children 6 to 14 years of age: One 5 mg chewable tablet. Safety and effectiveness in pediatric patients younger than 6 months of age with perennial allergic rhinitis have not been established.

Asthma and Allergic Rhinitis – Patients with both asthma and allergic rhinitis should take only one Montelukast dose daily in the evening.